May - June 2023

SARC is dedicated to driving collaborations among individuals and organizations worldwide committed to discovering, developing, and delivering the latest and most promising treatments for all types of sarcomas.

View this email in your browser



2023 SARC Semiannual Meeting Videos Ready to View

SARC is excited to announce that videos (with accompanying slides) from the 2023 SARC Semiannual Meeting, held at ASCO, June 2, 2022, are now ready for viewing. Speakers and moderators included Drs. Ping Chi, Mark Dickson, Jonathan Fletcher (SARC CSO), Patrick Grohar, Kevin Jones, Fariba Navid, Jan Phillip Novotny, Scott Okuno (SARC CMO), Joanna Przybyl, Richard Riedel, & Bill Tap. Please visit the link below to view and/or download now!

ASCO 2023

Platinum Sponsor of SARC Semiannual Meeting Spring 2023

We are proud to acknowledge and thank Boehringer Ingelheim, the Platinum Sponsor for the 2023 SARC Semi-Annual Meeting at ASCO. We are honored to have Boehringer Ingelheim as a partner supporting SARC’s mission of providing a collaborative infrastructure to make progress in the prevention, diagnosis, and treatment of sarcomas.

SARC Career Development Award

SARC is pleased to announce our newest Career Development Awardee Danh Truong, PhD (Postdoctoral Fellow, Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center). View announcement here

With the SARC Career Development Award, Dr. Truong aims to assess therapeutically targeting the androgen receptor (AR) and the PI3K/Akt/mTOR pathways and their possible role in neuroendocrine differentiation.

Dr. Truong received his PhD in Biomedical Engineering at Arizona State University in 2018. His central focus was developing bioengineered models to recapitulate tumor-stromal interactions and study the effect of cancer-associated fibroblasts on cancer cell invasion. Dr. Truong joined the lab of Dr. Joseph Ludwig at MD Anderson Cancer Center as a Postdoctoral Fellow in 2019 to study differentiation and cell fate in sarcoma. He leveraged his bioengineering and computational biology background to model differentiation and identify differentiation states in varying sarcoma subtypes. His current focus is studying desmoplastic small round cell tumors (DSRCT) and understanding epithelial and neuroendocrine differentiation.

To learn more about the Career Development Award, click here.

SARC Multidisciplinary Tumor Board

In May the international SARC Sarcoma Multidisciplinary Tumor Board (SMTB) held its inaugural session, reviewing three cases across a spectrum of sarcoma subtypes. View press release.


The (SMTB) brings together sarcoma experts, complementing and expanding the geographic reach of local, regional, or even national institutional tumor boards. The SMTB provides a uniquely focused forum for physicians from around the world to present sarcoma patient cases for in-depth, evidence-based discussion of tumor diagnosis and management of adults and children before or after diagnostic procedures, biopsies, surgery, or at relapse.


The SMTB facilitator is Gina D’Amato, MD, Associate Professor of Medicine at the Sylvester Comprehensive Cancer Center at the University of Miami, where she serves as a Sarcoma Medical Oncologist, Assistant Director of Clinical Research, and Medical Director of the Comprehensive Treatment Unit. Scott Okuno, MD, Professor of Oncology at Mayo Clinic, SARC Chief Medical Officer, serves as co-facilitator.


For more information, or to submit cases for consideration, clinicians are directed to click the link below.

Tumor Board

Sarcoma Awareness Month

SARC is honoring Sarcoma Awareness Month!


Please join us in celebrating the amazing achievements of the sarcoma community, including SARC’s scientific, clinical, and patient collaborators. Each July the sarcoma community highlights the latest milestones in sarcoma research, with a particular focus on the resulting impacts on patient survival and quality of life. Our social media platforms will also showcase several of the leading sarcoma disease advocacy groups, with whom SARC is honored to partner.


There are many ways you can support SARC during July such as, wear yellow to represent sarcoma, follow us on social media, share knowledge of SARC and the need for sarcoma research to grow, donate to SARC. Together, we CAN find a cure! 

Donate Here


SARC032: New Site Added

SARC is pleased to announce that University of Kansas is now open to enrollment for SARC032: Phase II Neoadjuvant Pembrolizumab with Radiotherapy and Adjuvant Pembrolizumab in Soft Tissue Sarcoma of the Extremity. To find out more about SARC032 and see more open sites, click here. Please direct questions to


At SARC, we understand that coming up with a clinical trial idea can be challenging. That's why we're here to assist you every step of the way. Whether you have a fully developed idea or need guidance, our team of experts is ready to help. With years of experience in clinical trial development, we have the knowledge and expertise to bring your idea to life. Simply follow the link below to get started and let SARC help you develop your clinical trial idea today!

Submit a Concept

Site Spotlight

Let's give a round of applause to Brooke Chrisman, our incredible Biorepository Protocol Coordinator at Nationwide Children’s Hospital! Brooke has been with Nationwide Children's Hospital since 2016, starting as a technician and currently leading the charge as the coordinator for the SARC trials. Her work involves collaborating with SARC Project Managers to manage and distribute biospecimens collected on sarcoma studies. How awesome is that? Brooke's role directly impacts future cancer research, and we couldn't be more grateful for her dedication. When she's not busy being a rockstar at work, Brooke loves to spend time with her husband and 5-year-old son. They enjoy visiting family and friends and exploring the great outdoors. On top of that, Brooke recently took up gardening and found a new love for plants. We are so lucky to work with Brooke , and we thank her for her continued support of SARC!


SARCTALK is a podcast series hosted by Dr. Scott Okuno, SARC Chief Medical Officer. This podcast series is available on popular platforms such as Spotify, Apple, and YouTube; it is also available directly on our website here. Thank you to SARCTALK sponsor Aadi Bioscience.

The May episode, we are honored to have Dr. James Chen, MD from Tempus Labs and The Ohio State University. Dr. Chen takes us on a fascinating journey into the world of bioinformatics and the pivotal role it plays in medical research today.

Listen Here

The June episode features Eric Lien from Rein In Sarcoma. Eric sheds light on the crucial role this organization plays in educating people about sarcoma, providing support to patients and caregivers, and funding research towards treatments for sarcoma.

Listen Here


Research Advocacy Council

The SARC Research Advisory Council held its quarterly meeting in June, with several new and ongoing collaborative opportunities to amplify the voices of patients while augmenting clinical services and trials.

The SARC Research Advocacy Council (RAC), established in 2019, is modeled on the National Cancer Institute’s to engage and train patient advocates to become “research advocates” across four key functions: advise, design, review, and disseminate. The RAC convenes regularly remotely and in person to learn and interface with sarcoma investigators, including exciting opportunities to “embed” in SARC’s current and planned clinical trials and/or helping to develop patient-facing research educational programs. 


The RAC is seeking additional motivated individuals who are passionate about helping to support and drive sarcoma research advancements, including RAC members in SARC’s current and in development clinical trials and other programs. We would appreciate any referrals if you know of an individual (or yourself) who might be interested in participating; please contact Lindsey Overman at


You can reach SARC by phone at 734.930.7600 or email at


SARC (Sarcoma Alliance for Research through Collaboration) is a non-profit organization dedicated to the development and support of research for the prevention, treatment, and cure of sarcoma – a cancer of the bone and connective tissues of the body.

SARC was formed in 2003 to conduct innovative and rigorous sarcoma research to advance the care of patients. Today, SARC collaborators include field-leading sarcoma physicians and researchers across the globe, working together to develop new strategies to improve outcomes for sarcoma patients.

Facebook  Twitter  Instagram